Ranked #2,263 of 8,699 institutional investors
Parkman Healthcare Partners LLC
Stamford, CT
$1.06B
US stock portfolio at live prices · today −$15.0M (−1.40%)
Live prices, last trade 12:50 PM ET
- Value at quarter end (Q3 2026)
- $1.11B
- Change from Q2 2026
- +$136.6M (+14.03%)
- Positions
- 86 · 25 new, 11 sold out
- Filed
- Nov 16, 2026
Not counted in the ranking: none$66.5M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesLLY 4.88%VRDN 4.85%PTCT 3.80%MBX 3.44%IQV 3.41%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| LLY Eli Lilly and Company | 38,119 | $51.5M | 4.88% | Added +9% |
| VRDN Viridian Therapeutics, Inc. | 1,674,834 | $51.2M | 4.85% | Added +22% |
| PTCT PTC Therapeutics, Inc. | 700,393 | $40.2M | 3.80% | Added +61% |
| MBX MBX Biosciences, Inc. | 716,542 | $36.3M | 3.44% | Reduced −10% |
| IQV IQVIA Holdings Inc. | 145,221 | $36.0M | 3.41% | Added +37% |
| DXCM DexCom, Inc. | 437,034 | $34.9M | 3.31% | Reduced −18% |
| XERS Xeris Biopharma Holdings, Inc. | 1,642,636 | $27.6M | 2.62% | Reduced −9% |
| SRRK Scholar Rock Holding Corporation | 540,000 | $27.1M | 2.56% | New |
| INBX Inhibrx Biosciences, Inc. | 360,260 | $25.5M | 2.42% | Added +40% |
| ANRO Alto Neuroscience Inc | 948,863 | $23.8M | 2.26% | Added +121% |
| CVS CVS Health Corporation | 286,286 | $23.4M | 2.22% | Reduced −27% |
| UNH UnitedHealth Group Incorporated | 55,871 | $19.2M | 1.82% | Unchanged |
| CRL Charles River Laboratories International, Inc. | 60,000 | $18.9M | 1.79% | New |
| KOD Kodiak Sciences Inc. | 186,000 | $18.2M | 1.72% | New |
| AGIO Agios Pharmaceuticals, Inc. | 633,312 | $17.8M | 1.69% | Reduced −5% |
| ASMB Assembly Biosciences, Inc. | 796,256 | $17.7M | 1.67% | Added +10% |
| AMLX Amylyx Pharmaceuticals, Inc. | 675,101 | $17.4M | 1.65% | Added +69% |
| ABT Abbott Laboratories | 165,184 | $17.2M | 1.63% | New |
| THC Tenet Healthcare Corporation | 63,854 | $16.8M | 1.59% | Reduced −34% |
| ADPT Adaptive Biotechnologies Corporation | 600,053 | $16.6M | 1.57% | Added +23% |
| TARS Tarsus Pharmaceuticals, Inc. | 213,395 | $15.9M | 1.51% | Added +42% |
| WST West Pharmaceutical Services, Inc. | 40,000 | $15.7M | 1.49% | New |
| INSM Insmed Incorporated | 105,057 | $15.2M | 1.44% | New |
| SUPN Supernus, Inc. | 521,580 | $15.2M | 1.44% | Added +43% |
| SI Shoulder Innovations, Inc. | 726,857 | $14.5M | 1.37% | Added +221% |
| CDNA CareDx, Inc. | 200,410 | $14.2M | 1.35% | Reduced −1% |
| CARL Carlsmed, Inc. | 779,757 | $13.7M | 1.29% | Added +31% |
| EWTX Edgewise Therapeutics, Inc. | 327,954 | $13.2M | 1.25% | Reduced −43% |
| CYRX Cryoport, Inc. | 678,568 | $12.9M | 1.23% | Added +33% |
| COAG Hemab Therapeutics Holdings, Inc. | 329,251 | $12.9M | 1.22% | Added +632% |
| ANIP ANI Pharmaceuticals, Inc. | 185,855 | $12.8M | 1.21% | Reduced −8% |
| ATRC AtriCure, Inc. | 225,248 | $12.5M | 1.18% | New |
| WAT Waters Corporation | 27,878 | $12.3M | 1.17% | Reduced −8% |
| AVAH Aveanna Healthcare Holdings Inc. | 1,126,599 | $12.3M | 1.16% | Added +58% |
| CSTL Castle Biosciences, Inc. | 367,908 | $12.1M | 1.15% | Added +154% |
| RCUS Arcus Biosciences, Inc. | 675,516 | $10.7M | 1.01% | Reduced −27% |
| VCEL Vericel Corporation | 180,247 | $10.5M | 0.99% | New |
| SNDX Syndax Pharmaceuticals, Inc. | 1,105,057 | $9.9M | 0.93% | Added +26% |
| TFX Teleflex Incorporated | 60,000 | $9.8M | 0.92% | New |
| SIBN SI-BONE, Inc. | 392,803 | $9.4M | 0.89% | Added +20% |
| SDGR Schrödinger, Inc. | 375,000 | $8.8M | 0.84% | New |
| VTRS Viatris Inc. | 443,112 | $8.6M | 0.82% | Added +122% |
| NVCT Nuvectis Pharma, Inc. | 425,351 | $8.3M | 0.78% | New |
| PODD Insulet Corporation | 59,912 | $8.2M | 0.77% | Reduced −54% |
| IRTC iRhythm Holdings, Inc. | 85,743 | $8.1M | 0.77% | Added +27% |
| FDMT 4D Molecular Therapeutics, Inc. | 772,177 | $8.0M | 0.76% | Reduced −19% |
| XENE Xenon Pharmaceuticals Inc. | 208,088 | $7.7M | 0.73% | Reduced −48% |
| COGT Cogent Biosciences, Inc. | 275,835 | $7.4M | 0.70% | Added +9% |
| STOK Stoke Therapeutics, Inc. | 266,983 | $7.2M | 0.68% | Reduced −25% |
| INSP Inspire Medical Systems, Inc. | 130,000 | $7.2M | 0.68% | New |
| NVST Envista Holdings Corporation | 281,002 | $6.5M | 0.61% | Reduced −49% |
| IMNM Immunome, Inc. | 396,444 | $6.3M | 0.60% | Reduced −33% |
| AVTX Avalo Therapeutics, Inc. | 929,432 | $6.3M | 0.59% | Added +21% |
| TEM Tempus AI, Inc. | 110,000 | $6.1M | 0.58% | New |
| DTIL Precision BioSciences, Inc. | 836,756 | $6.0M | 0.57% | New |
| RCEL AVITA Medical, Inc. | 350,581 | $5.6M | 0.53% | New |
| ALNY Alnylam Pharmaceuticals, Inc. | 35,159 | $5.2M | 0.50% | Reduced −31% |
| MMED MiniMed Group, Inc. | 321,499 | $5.2M | 0.49% | Added +42% |
| ORKA Oruka Therapeutics, Inc. | 53,221 | $5.0M | 0.47% | Reduced −53% |
| GPCR Structure Therapeutics Inc. | 283,763 | $4.6M | 0.44% | Reduced −42% |
| VIR Vir Biotechnology, Inc. | 517,377 | $4.4M | 0.42% | Added +9% |
| MLYS Mineralys Therapeutics, Inc. | 314,015 | $4.4M | 0.41% | Reduced −17% |
| CLYM Climb Bio Inc | 468,208 | $4.3M | 0.41% | Reduced −17% |
| KIDS OrthoPediatrics Corp. | 125,181 | $4.0M | 0.38% | New |
| ABSI Absci Corporation | 478,652 | $3.6M | 0.34% | Reduced −46% |
| OABI OmniAb, Inc. | 726,163 | $3.4M | 0.33% | New |
| XGN Exagen Inc. | 926,548 | $3.4M | 0.32% | New |
| ERAS Erasca, Inc. | 231,511 | $3.2M | 0.31% | Reduced −11% |
| DRUG Bright Minds Biosciences Inc. | 148,227 | $3.0M | 0.28% | Reduced −28% |
| IRON Disc Medicine, Inc. | 35,000 | $2.6M | 0.25% | New |
| OPRX OptimizeRx Corporation | 381,353 | $2.6M | 0.24% | Added +9% |
| LUNG Pulmonx Corporation | 853,986 | $2.3M | 0.21% | Added +32% |
| IVA Inventiva S.A. | 651,100 | $2.1M | 0.20% | New |
| LMRI Lumexa Imaging Holdings, Inc. | 140,416 | $2.0M | 0.19% | New |
| ATEC Alphatec Holdings, Inc. | 289,434 | $2.0M | 0.19% | Reduced −36% |
| LQDA Liquidia Corporation | 35,000 | $1.9M | 0.18% | New |
| AORT Artivion, Inc. | 101,330 | $1.9M | 0.18% | Reduced −27% |
| APMD Apnimed, Inc. | 105,294 | $1.7M | 0.16% | New |
| ANNX Annexon, Inc. | 497,696 | $1.6M | 0.15% | Reduced −22% |
| NSPR InspireMD, Inc. | 2,416,518 | $1.3M | 0.13% | Unchanged |
| FOCL EDAP TMS S.A. | 491,620 | $1.3M | 0.12% | Added +218% |
| LYEL Lyell Immunopharma, Inc. | 85,758 | $1.2M | 0.11% | New |
| UPB Upstream Bio, Inc. | 618,056 | $1.1M | 0.10% | Reduced −34% |
| OVID Ovid Therapeutics Inc. | 215,462 | $471K | <0.1% | Added +9% |
| ALGS Aligos Therapeutics, Inc. | 325,537 | $407K | <0.1% | New |
| EYPT EyePoint, Inc. | 486,427 | $117K | <0.1% | Reduced −62% |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| ZBH Zimmer Biomet Holdings, Inc. | 232,557 | $23.6M |
| SYK Stryker Corporation | 67,973 | $21.3M |
| BCRX BioCryst Pharmaceuticals, Inc. | 1,624,279 | $11.8M |
| AMRX Amneal Pharmaceuticals, Inc. | 541,190 | $11.5M |
| RMD ResMed Inc. | 32,983 | $7.8M |
| BSX Boston Scientific Corporation | 180,481 | $7.7M |
| ALGN Align Technology, Inc. | 36,963 | $5.8M |
| WAY Waystar Holding Corp. | 203,986 | $5.4M |
| AXSM Axsome Therapeutics, Inc. | 10,000 | $1.3M |
| EIKN Eikon Therapeutics, Inc. | 256,053 | $1.2M |
| SPRY ARS Pharmaceuticals, Inc. | 102,700 | $323K |